Conclusion In recent years, the diabetes drug market has continued to grow
The body requires nine essential amino acids to build and support muscle
Nearly all PCOS patients prescribed semaglutide or tirzepatide also had obesity or type 2 diabetes, suggesting use remains primarily tied to metabolic indications, though broader interest in PCOS benefits is growing within scientific literature
So, pharmaceutical companies started investigating the use of GLP-1s for weight-management purposes, and the first GLP-1 weight-loss drug, Saxenda (liraglutide), was approved by FDA in 2014 (it was previously approved to treat diabetes under the name Victoza)
This brand has by far the best flavor and texture and I love that there are some other vitamins and supplements as well to help support overall health
In addition, do NOT give the false promise to patients that the 3 mg dose will bring down their Accucheck readings